V Kyle1, B L Hazleman. 1. Rheumatology Research Unit, Addenbrooke's Hospital, Cambridge, United Kingdom.
Abstract
OBJECTIVES: To examine the clinical course of polymyalgia rheumatica (PMR) and giant cell arteritis (GCA) in a prospective study, after the initial two months. METHODS:Seventy four patients with PMR/GCA were followed for a median of 60 weeks. Detailed clinical and laboratory records were made on each visit. RESULTS: Twenty per cent of patients with PMR developed GCA and 24% of patients with GCA developed PMR from the onset of symptoms. After two months, most patients experienced at least one relapse. Relapses and persistence of abnormal symptoms and signs were most common in patients with both PMR and GCA and least common in those with GCA alone. Relapses were most common in the first year and 54% occurred in association with steroid reduction. Major complications were rare. Laboratory parameters and temporal artery histology were not helpful in predicting relapse. Only 24% of patients were able to stop steroid treatment after two years. CONCLUSIONS: Clinicians should consider more frequent review in patients at times of steroid reduction and especially within the first six months of treatment.
RCT Entities:
OBJECTIVES: To examine the clinical course of polymyalgia rheumatica (PMR) and giant cell arteritis (GCA) in a prospective study, after the initial two months. METHODS: Seventy four patients with PMR/GCA were followed for a median of 60 weeks. Detailed clinical and laboratory records were made on each visit. RESULTS: Twenty per cent of patients with PMR developed GCA and 24% of patients with GCA developed PMR from the onset of symptoms. After two months, most patients experienced at least one relapse. Relapses and persistence of abnormal symptoms and signs were most common in patients with both PMR and GCA and least common in those with GCA alone. Relapses were most common in the first year and 54% occurred in association with steroid reduction. Major complications were rare. Laboratory parameters and temporal artery histology were not helpful in predicting relapse. Only 24% of patients were able to stop steroid treatment after two years. CONCLUSIONS: Clinicians should consider more frequent review in patients at times of steroid reduction and especially within the first six months of treatment.
Authors: W S Smellie; J O Forth; C A M McNulty; L Hirschowitz; D Lilic; R Gosling; D Bareford; E Logan; K G Kerr; G P Spickett; J Hoffman; A Galloway; C A Bloxham Journal: J Clin Pathol Date: 2006-02 Impact factor: 3.411
Authors: Izzat Shbeeb; Divya Challah; Shafay Raheel; Cynthia S Crowson; Eric L Matteson Journal: Arthritis Care Res (Hoboken) Date: 2018-02-22 Impact factor: 4.794
Authors: A Chandran; Pr D Udayakumar; T A Kermani; K J Warrington; C S Crowson; E L Matteson Journal: Clin Exp Rheumatol Date: 2015-05-26 Impact factor: 4.473
Authors: M J van der Veen; H J Dinant; C van Booma-Frankfort; G A van Albada-Kuipers; J W Bijlsma Journal: Ann Rheum Dis Date: 1996-04 Impact factor: 19.103
Authors: Jung Hwa Lee; Sang Tae Choi; Jin Su Kim; Bo Young Yoon; Seung-Ki Kwok; Hyun-Sook Kim; Yun Sung Kim; Jung-Soo Song; Sang-Heon Lee; Hae-Rim Kim Journal: Rheumatol Int Date: 2012-11-27 Impact factor: 2.631
Authors: Christian Dejaco; Christina Duftner; Marco A Cimmino; Bhaskar Dasgupta; Carlo Salvarani; Cynthia S Crowson; Hilal Maradit-Kremers; Andrew Hutchings; Eric L Matteson; Michael Schirmer Journal: Ann Rheum Dis Date: 2010-11-19 Impact factor: 19.103
Authors: Bhaskar Dasgupta; Marco A Cimmino; Hilal Maradit-Kremers; Wolfgang A Schmidt; Michael Schirmer; Carlo Salvarani; Artur Bachta; Christian Dejaco; Christina Duftner; Hanne Slott Jensen; Pierre Duhaut; Gyula Poór; Novák Pál Kaposi; Peter Mandl; Peter V Balint; Zsuzsa Schmidt; Annamaria Iagnocco; Carlotta Nannini; Fabrizio Cantini; Pierluigi Macchioni; Nicolò Pipitone; Montserrat Del Amo; Georgina Espígol-Frigolé; Maria C Cid; Víctor M Martínez-Taboada; Elisabeth Nordborg; Haner Direskeneli; Sibel Zehra Aydin; Khalid Ahmed; Brian Hazleman; Barbara Silverman; Colin Pease; Richard J Wakefield; Raashid Luqmani; Andy Abril; Clement J Michet; Ralph Marcus; Neil J Gonter; Mehrdad Maz; Rickey E Carter; Cynthia S Crowson; Eric L Matteson Journal: Ann Rheum Dis Date: 2012-04 Impact factor: 19.103